4Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin,2005;55(1) :10-30.
5Tran PT, Su Z, Lee P, et al. Prognostic factors for outcomes and complications for primary squamous cell carcinoma of the vagina treated with radiation. Gynecol Oncol, 2007; 105 (3): 641-649.
6Tjalma WAA, Monaghan JM, Lopes AB, et al. The role of surgery in invasive squamous carcinoma of the vagina. Gynecol Oncol,2001 ;81(3) : 360-365.
7Shah CA, Goff BA, Lowe K, et al. Factors affecting risk of mortality in women with vaginal can cer. Obstet Gynecol, 2009 ; 113(5) : 1038-1045.
8Otton GR, Nicklin JL, Diekie GJ, et al. Early-stage vaginal carcinoma-an analysis of 70 patients. Int J Gyneeol Cancer, 2004 ; 14(2) : 304-310.
9Stock RG, Chen AS, Seski J. A 30-year experience in the management of primary carcinoma of the vagina: analysis of prognostic factors and treatment modalities . Gynecol Oncol, 1995;56(1) :45-52.
10Mock U, Kucera H, Fellner C, etal. High-dose-rate (HDR) hrachytherapy with or without external bean radiotherapy in the treatment of primary vaginal carcinoma., long term result and side effect. Int J Radiat Oncol Biol Phys,2003;56(4):950- 957.
